Analyzing Metabolic States of Adipogenic and Osteogenic Differentiation in Human Mesenchymal Stem Cells via Genome Scale Metabolic Model Reconstruction.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Sigmarsdottir, Thora BjorgMcGarrity, Sarah
Yurkovich, James T
Rolfsson, Óttar
Sigurjónsson, Ólafur Eysteinn
Issue Date
2021-06-04
Metadata
Show full item recordCitation
Sigmarsdottir TB, McGarrity S, Yurkovich JT, Rolfsson Ó, Sigurjónsson ÓE. Analyzing Metabolic States of Adipogenic and Osteogenic Differentiation in Human Mesenchymal Stem Cells via Genome Scale Metabolic Model Reconstruction. Front Cell Dev Biol. 2021;9:642681. Published 2021 Jun 4. doi:10.3389/fcell.2021.642681Abstract
Since their initial discovery in 1976, mesenchymal stem cells (MSCs) have been gathering interest as a possible tool to further the development and enhancement of various therapeutics within regenerative medicine. However, our current understanding of both metabolic function and existing differences within the varying cell lineages (e.g., cells in either osteogenesis or adipogenesis) is severely lacking making it more difficult to fully realize the therapeutic potential of MSCs. Here, we reconstruct the MSC metabolic network to understand the activity of various metabolic pathways and compare their usage under different conditions and use these models to perform experimental design. We present three new genome-scale metabolic models (GEMs) each representing a different MSC lineage (proliferation, osteogenesis, and adipogenesis) that are biologically feasible and have distinctive cell lineage characteristics that can be used to explore metabolic function and increase our understanding of these phenotypes. We present the most distinctive differences between these lineages when it comes to enriched metabolic subsystems and propose a possible osteogenic enhancer. Taken together, we hope these mechanistic models will aid in the understanding and therapeutic potential of MSCs. Keywords: GEM; MSCs; adipogenesis; metabolic differences; metabolic reconstruction; osteogenesis.Description
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked DownloadAdditional Links
https://www.frontiersin.org/articles/10.3389/fcell.2021.642681/fullhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212021/
Rights
Copyright © 2021 Sigmarsdottir, McGarrity, Yurkovich, Rolfsson and Sigurjónsson.ae974a485f413a2113503eed53cd6c53
10.3389/fcell.2021.642681
Scopus Count
Collections
Related articles
- A glance on the role of actin in osteogenic and adipogenic differentiation of mesenchymal stem cells.
- Authors: Khan AU, Qu R, Fan T, Ouyang J, Dai J
- Issue date: 2020 Jul 16
- The osteogenic or adipogenic lineage commitment of human mesenchymal stem cells is determined by protein kinase C delta.
- Authors: Lee S, Cho HY, Bui HT, Kang D
- Issue date: 2014 Nov 25
- Reversibly immortalized human umbilical cord-derived mesenchymal stem cells (UC-MSCs) are responsive to BMP9-induced osteogenic and adipogenic differentiation.
- Authors: Shu Y, Yang C, Ji X, Zhang L, Bi Y, Yang K, Gong M, Liu X, Guo Q, Su Y, Qu X, Nan G, Zhao C, Zeng Z, Yu X, Zhang R, Yan S, Lei J, Wu K, Wu Y, An L, Huang S, Gong C, Yuan C, Liu W, Huang B, Feng Y, Zhang B, Dai Z, Shen Y, Luo W, Wang X, Haydon RC, Luu HH, Reid RR, Wolf JM, Lee MJ, He TC, Li Y
- Issue date: 2018 Nov
- Suppression of SPRY4 Promotes Osteogenic Differentiation and Bone Formation of Mesenchymal Stem Cell.
- Authors: Park S, Arai Y, Kim BJ, Bello A, Ashraf S, Park H, Park KS, Lee SH
- Issue date: 2019 Dec
- Activin Receptor 2 Antagonization Impairs Adipogenic and Enhances Osteogenic Differentiation in Mouse Adipose-Derived Stem Cells and Mouse Bone Marrow-Derived Stem Cells In Vitro and In Vivo.
- Authors: Wallner C, Huber J, Drysch M, Schmidt SV, Wagner JM, Dadras M, Dittfeld S, Becerikli M, Jaurich H, Lehnhardt M, Behr B
- Issue date: 2019 Mar 15